0.60 USD
↗ 0.02 (2.80%)AT CLOSE (03:59 PM EDT)
Citius Oncology, Inc. Common Stock
CTORNASDAQ • USD
0.56
↘ 0.04 (5.99%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
0.56
↘ 0.04 (5.99%)
Market: CLOSED
Citius Oncology, Inc. Common Stock (CTOR) is currently trading at $0.58. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. CTOR is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$0.63
High?$0.69
Low?$0.54
Prev. Close?$0.58
Volume?885.3K
Avg. Volume?95.0K
VWAP?$0.63
Rel. Volume?9.32x
Bid / Ask
Bid?$0.55 × 1.1K
Ask?$0.58 × 100
Spread?$0.03
Midpoint?$0.57
Valuation & Ratios
Market Cap?61.3M
Shares Out?93.0M
Float?26.9M
Float %?28.9%
P/E Ratio?N/A
P/B Ratio?1.52
EPS?-$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Employees
N/A
Market Cap
61.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-08-13
Address
11 COMMERCE DRIVE
CRANFORD, NJ 07016
Phone: (908) 967-6677
CRANFORD, NJ 07016
Phone: (908) 967-6677
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?94
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.30Distress
Confidence?36%Very Low
Short InterestLow
Short % of Float?0.85%Low
Short Interest?227.5K
Days to Cover?2.7
Free Float26.9M
Avg Daily Volume84.8K
Settlement Date2026-10-15
Financial Health
Current Ratio?0.73Weak
Quick Ratio?0.34Weak
Cash Ratio?0.28Low
Debt/Equity?0.16Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.52CHEAP▾
Peers100
S&P87
P/S?8.63HIGH▾
Peers100
S&P11
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?7.20HIGH▾
Peers100
S&P19
Returns & Efficiency
ROE?-114.1%WEAK▾
S&P3
ROA?-41.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-19389240
Enterprise Value?$51.2M
Fundamentals ratios updated end of day